Showing results (6781-6790 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|January 18, 2003
Thymidylate synthase expression in rectal cancer and proliferation, assessed by cyclin A and Ki-67 expressionDavid Edler, Marja Hallström, Peter Ragnhammar, et al.Anticancer Research|January 18, 2003
Modulation of cdk2, cyclin D1, p16INK4a, p21WAF and p27Kip1 expression in endothelial cells by TNF/IFN gammaOlivier Dormond, Ferdy J Lejeune, Curzio RueggAnticancer Research|January 18, 2003
Expression of p57kip2 and its clinical relevance in epithelial ovarian tumorsLi Sui, Youyi Dong, Masayuki Ohno, et al.Anticancer Research|January 18, 2003
Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cellsAntje Ludwig, Manfred Dietel, Hermann LageAnticancer Research|January 18, 2003
Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimuriumShaoping Mei, Jan Theys, Willy Landuyt, et al.Anticancer Research|January 18, 2003
Selective protection of non-cancer cells by hypothermiaZdenka MatijasevicAnticancer Research|January 18, 2003
Amplified Muc1-specific gene expression in colon cancer cells utilizing a binary system in adenoviral vectorsAndreas Block, Dragan Milasinovic, Juergen Mueller, et al.Anticancer Research|January 18, 2003
Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancersMikako Yamada, Naoki Tsuji, Masashi Nakamura, et al.Anticancer Research|January 18, 2003
Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substanceYoshiyuki Kimura, Masahiko Taniguchi, Kimiye BabaAnticancer Research|January 18, 2003
Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virusChristian Teschendorf, Kenneth H Warrington, Dietmar W Siemann, et al.Pageof 2,589